Endotoxin tolerance of adrenal gland: Attenuation of corticosterone production in response to lipopolysaccharide and adrenocorticotropic hormone

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 518-526

  Liu, Shujuan ^a   Zhu, Xiaoyan ^a   Liu, Yujian ^a   Wang, Changnan ^a   Wang, Shan ^a   Tang, Xiaolu ^a   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

adrenal gland; adrenocorticotropic hormone; corticosteroid; lipopolysaccharide; rechallenge; sepsis

Indexed keywords

CORTICOTROPIN; ENDOTOXIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ADRENAL CORTEX; ADRENAL INSUFFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME METABOLISM; FEMORAL ARTERY; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS; ZONA FASCICULATA;

EID: 79952190267     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206b980     Document Type: Article

References (47)

1. Tsigos C, Chrousos GP: Hypothalamicpituitary- adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53: 865-871. (Pubitemid 35282615)
2. Mesotten D, Vanhorebeek I, Van den Berghe G: The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 2008; 4:496-505.
3. Prigent H, Maxime V, Annane D: Clinical review: Corticotherapy in sepsis. Crit Care: 2004; 8:122-129. (Pubitemid 38436420)
4. Venkataraman S, Munoz R, Candido C, et al: The hypothalamic-pituitary- adrenal axis in critical illness. Rev Endocr Metab Disord 2007; 8:365-373.
5. Neary N, Nieman L: Adrenal insufficiency: Etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 2010; 17:217-223.
6. Dimopoulou I, Tsagarakis S: Hypothalamicpituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury. Intensive Care Med 2005; 31:1020-1028. (Pubitemid 41125332)
7. Tsai MH, Peng YS, Chen YC, et al: Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006; 43:673-681.
8. Lipiner-Friedman D, Sprung CL, Laterre PF, et al: Adrenal function in sepsis: The retrospective Corticus cohort study. Crit Care Med 2007; 35:1012-1018. (Pubitemid 46598949)
9. Marik PE, Pastores SM, Annane D, et al: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949.
10. Cheng B, Xie G, Yao S, et al: Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007; 35:2538-2546. (Pubitemid 351339014)
11. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554. (Pubitemid 36437931)
12. Dinarello CA: Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 1996; 216:134-165.
13. Beishuizen A, Thijs LG: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 2003; 9:3-24. (Pubitemid 36322480)
14. Kakucska I, Qi Y, Clark BD, et al: Endotoxininduced corticotropin- releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 1993; 133: 815-821. (Pubitemid 23238897)
15. Givalois L, Siaud P, Mekaouche M, et al: Early hypothalamic activation of combined Fos and CRH41 immunoreactivity and of CRH41 release in push-pull cannulated rats after systemic endotoxin challenge. Mol Chem Neuropathol 1995; 26:171-186.
16. Singru PS, Sánchez E, Acharya R, et al: Mitogen- activated protein kinase contributes to lipopolysaccharide- induced activation of corticotropin- releasing hormone synthesizing neurons in the hypothalamic paraventricular nucleus. Endocrinology 2008; 149:2283-2292. (Pubitemid 351574481)
17. Elenkov IJ, Kovács K, Kiss J, et al: Lipopolysaccharide is able to bypass corticotrophinreleasing factor in affecting plasma ACTH and corticosterone levels: Evidence from rats with lesions of the paraventricular nucleus. J Endocrinol 1992; 133:231-236.
18. Elenkov IJ, Kiss J, Stark E, et al: CRFdependent and CRF-independent mechanisms involved in hypophysial-adrenal system activation by bacterial endotoxin. Acta Physiol Hung 1992; 79:355-363.
19. Bethin KE, Vogt SK, Muglia LJ: Interleukin- 6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Nat Acad Sci USA 2000; 97:9317-9322. (Pubitemid 30626716)
20. Vakharia K, Hinson JP: Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenasedependent mechanism. Endocrinology 2005; 146:1398-1402. (Pubitemid 40289328)
21. Enríquez de Salamanca A, García R: Response of rat fasciculata-reticularis cells in primary culture to bacterial lipopolysaccharide. Microbes Infect 2005; 7:1077-1086.
22. Beeson PB: Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med 1946; 61:248-250.
23. Neter E: Endotoxins and the immune response. Curr Top Microbiol Immunol 1969; 47:82-124.
24. West MA, Heagy W: Endotoxin tolerance: A review. Crit Care Med 2002; 30:S64-S73. (Pubitemid 34131164)
25. Carlson DE, Chiu WC, Scalea TM: Cecal ligation and puncture in rats interrupts the circadian rhythms of corticosterone and adrenocortical responsiveness to adrenocorticotrophic hormone. Crit Care Med 2006; 34: 1178-1184.
26. Mattos GE, Lotfi CF: Differences between the growth regulatory pathways in primary rat adrenal cells and mouse tumor cell line. Mol Cell Endocrinol 2005; 245:31-42. (Pubitemid 43049743)
27. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987; 56:279-285. (Pubitemid 17158816)
28. Zhu XY, Liu SJ, Liu YJ, et al: Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide- treated macrophages. Cell Mol Life Sci 2010; 67:1119-1132.
29. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408. (Pubitemid 34164012)
30. Zacharowski K, Zacharowski PA, Koch A, et al: Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic in- flammatory response syndrome. Proc Nat Acad Sci USA 2006; 103:6392-6397.
31. Engeland WC, Ennen WB, Elayaperumal A, et al: Zone-specific cell proliferation during compensatory adrenal growth in rats. Am J Physiol Endocrinol Metab 2005; 288: E298-E306. (Pubitemid 40110635)
32. Sewer MB, Dammer EB, Jagarlapudi S: Transcriptional regulation of adrenocortical steroidogenic gene expression. Drug Metab Rev 2007; 39:371-388. (Pubitemid 47364558)
33. Maxime V, Lesur O, Annane D: Adrenal insufficiency in septic shock. Clin Chest Med 2009; 30:17-27, vii.
34. Marik PE, Kiminyo K, Zaloga GP: Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Crit Care Med 2002; 30:1267-1273. (Pubitemid 34620970)
35. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145. (Pubitemid 36151163)
36. Annane D, Sébille V, Troché G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045. (Pubitemid 30112218)
37. Biswas SK, Lopez-Collazo E: Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol 2009; 30:475-487.
38. Medvedev AE, Kopydlowski KM, Vogel SN: Inhibition of lipopolysaccharide- induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000; 164: 5564-5574. (Pubitemid 30389795)
39. Sato S, Takeuchi O, Fujita T, et al: A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 2002; 14:783-791. (Pubitemid 34814639)
40. Zhu X, Liu Y, Liu S, et al: Lipopolysaccharide primes macrophages to increase nitric oxide production in response to Staphylococcus aureus. Immunol Lett 2007; 112:75-81. (Pubitemid 47379850)
41. Peck OM, Williams DL, Breuel KF, et al: Differential regulation of cytokine and chemokine production in lipopolysaccharide- induced tolerance and priming. Cytokine 2004; 26:202-208. (Pubitemid 38639748)
42. Peck OM, Fan H, Tempel GE, et al: Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: Role of interferon-gamma. Shock 2004; 21:254-260.
43. Lehner MD, Morath S, Michelsen KS, et al: Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001; 166:5161-5167. (Pubitemid 32280731)
44. Fan H, Cook JA: Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004; 10:71-84.
45. Del Fresno C, Gómez-Piñ a V, Lores V, et al: Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: downregulation of TREM-1 as putative underlying mechanism. PLoS One 2008; 3:e2667.
46. Van't Veer C, Van den Pangaart PS, Van Zoelen MA, et al: Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model, J Immunol, 2007, 179, 7110-7120.
47. Prigent H, Maxime V, Annane D: Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 2004; 8:243-252 (Pubitemid 39144714)